• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Persistence of IgG response to SARS-CoV-2.

作者信息

Duysburgh Els, Mortgat Laure, Barbezange Cyril, Dierick Katelijne, Fischer Natalie, Heyndrickx Leo, Hutse Veronik, Thomas Isabelle, Van Gucht Steven, Vuylsteke Bea, Ariën Kevin K, Desombere Isabelle

机构信息

Department of Epidemiology and Public Health, Sciensano, 1050 Brussels, Belgium.

Department of Epidemiology and Public Health, Sciensano, 1050 Brussels, Belgium; European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.

出版信息

Lancet Infect Dis. 2021 Feb;21(2):163-164. doi: 10.1016/S1473-3099(20)30943-9. Epub 2020 Dec 17.

DOI:10.1016/S1473-3099(20)30943-9
PMID:33341124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7833610/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/7833610/33e0ae546528/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/7833610/33e0ae546528/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d92e/7833610/33e0ae546528/fx1_lrg.jpg

相似文献

1
Persistence of IgG response to SARS-CoV-2.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的IgG反应的持续性。
Lancet Infect Dis. 2021 Feb;21(2):163-164. doi: 10.1016/S1473-3099(20)30943-9. Epub 2020 Dec 17.
2
Immunodominant antibody germlines in COVID-19.COVID-19 中的优势免疫原性抗体胚系。
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20210281.
3
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.有或无前新冠病毒感染启动的情况下，SARS-CoV-2疫苗BNT162b2的抗体依赖性中和能力
J Intern Med. 2021 Dec;290(6):1272-1274. doi: 10.1111/joim.13366. Epub 2021 Aug 2.
4
Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.新冠病毒感染后6个月内肾移植受者体内抗新冠病毒抗体的下降与丧失
Kidney Int. 2021 Feb;99(2):486-488. doi: 10.1016/j.kint.2020.12.001.
5
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.COVID-19 恢复期血浆供者中 SARS-CoV-2 抗体的持久性：依赖于检测方法和在血清学监测中的适用性。
Transfusion. 2021 Sep;61(9):2677-2687. doi: 10.1111/trf.16555. Epub 2021 Jun 20.
6
Potent and Persistent Antibody Response in COVID-19 Recovered Patients.新冠康复患者体内强大且持久的抗体反应
Front Immunol. 2021 May 28;12:659041. doi: 10.3389/fimmu.2021.659041. eCollection 2021.
7
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.COVID-19 恢复期个体中中和抗体的时间成熟提高了对流行的 SARS-CoV-2 变体的效力和广度。
Immunity. 2021 Aug 10;54(8):1841-1852.e4. doi: 10.1016/j.immuni.2021.06.015. Epub 2021 Jul 2.
8
Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre.英国一家肾移植中心工作人员在当前新冠疫情期间的新冠病毒2型免疫球蛋白G抗体血清流行率。
Transpl Int. 2021 Feb;34(2):382-383. doi: 10.1111/tri.13791.
9
Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020.截至 2020 年 9 月 30 日美国无症状成年人群体中 SARS-CoV-2 抗体的血清流行率。
JAMA Netw Open. 2021 Mar 1;4(3):e211552. doi: 10.1001/jamanetworkopen.2021.1552.
10
No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study.先前存在的蜱传脑炎病毒抗体对严重急性呼吸综合征冠状病毒 2 没有中和作用：一项前瞻性医护人员研究。
Sci Rep. 2021 Dec 17;11(1):24198. doi: 10.1038/s41598-021-03685-y.

引用本文的文献

1
Serosurveillance of COVID-19 amongst health care workers in a teaching institution - A prospective cohort study in Puducherry district.某教学机构医护人员中新冠病毒病的血清学监测——在本地治里地区开展的一项前瞻性队列研究
J Family Med Prim Care. 2024 May;13(5):1917-1921. doi: 10.4103/jfmpc.jfmpc_1488_23. Epub 2024 May 24.
2
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity.B 细胞和抗体对 SARS-CoV-2 的反应：感染、疫苗接种和混合免疫。
Cell Mol Immunol. 2024 Feb;21(2):144-158. doi: 10.1038/s41423-023-01095-w. Epub 2023 Nov 10.
3
The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?

本文引用的文献

1
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.
2
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.人类感染 SARS-CoV-2 后三个月内中和抗体反应的纵向观察和下降。
Nat Microbiol. 2020 Dec;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
3
Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.
新型冠状病毒肺炎康复后严重急性呼吸综合征冠状病毒2中和抗体的持久性：一年观察。是否需要接种严重急性呼吸综合征冠状病毒2疫苗加强针？
Cent Eur J Immunol. 2023;48(2):92-96. doi: 10.5114/ceji.2023.126206. Epub 2023 Mar 28.
4
Validation of a rapid SARS-CoV-2 antibody test in general practice.在全科医学中验证一种快速 SARS-CoV-2 抗体检测方法。
BMJ Open. 2023 May 2;13(5):e069997. doi: 10.1136/bmjopen-2022-069997.
5
Assessment of the levels of antispike SARS-CoV-2 IgG antibodies and their association with clinical characteristics in cohort of patients in Saudi Arabia.沙特阿拉伯患者队列中抗新冠病毒刺突蛋白IgG抗体水平及其与临床特征的关联评估
J Family Med Prim Care. 2022 Nov;11(11):7372-7377. doi: 10.4103/jfmpc.jfmpc_1369_22. Epub 2022 Dec 16.
6
Immunological evaluation of young unvaccinated patients with Turner syndrome after COVID-19.COVID-19 后免疫功能未成熟的特纳综合征未接种疫苗患者的免疫评估。
Int J Infect Dis. 2023 Apr;129:207-215. doi: 10.1016/j.ijid.2023.01.042. Epub 2023 Feb 8.
7
High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya.高血清 IgG 和 IgM 抗体对 SARS-CoV-2 的阳性率在肯尼亚西部疫苗接种开展的同时，在无症状和有症状的个体中。
PLoS One. 2022 Dec 22;17(12):e0272751. doi: 10.1371/journal.pone.0272751. eCollection 2022.
8
Guest edited collection serological study of SARS-CoV-2 antibodies in japanese cats using protein-A/G-based ELISA.使用基于蛋白 A/G 的 ELISA 对日本猫进行 SARS-CoV-2 抗体的客座编辑专题研究。
BMC Vet Res. 2022 Dec 21;18(1):443. doi: 10.1186/s12917-022-03527-7.
9
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.肯尼亚三家转诊医院产前护理诊所的 SARS-CoV-2 IgG 血清监测：2020-21 年重复横断面调查。
PLoS One. 2022 Oct 14;17(10):e0265478. doi: 10.1371/journal.pone.0265478. eCollection 2022.
10
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.在比利时初级保健提供者中针对 SARS-CoV-2 的抗体的流行率、发生率和持久性：一项前瞻性队列研究，随访 12 个月。
BMJ Open. 2022 Sep 19;12(9):e065897. doi: 10.1136/bmjopen-2022-065897.
感染 SARS-CoV-2 及其他冠状病毒后的免疫反应：快速综述。
Rev Med Virol. 2021 Mar;31(2):e2162. doi: 10.1002/rmv.2162. Epub 2020 Sep 23.
4
Humoral Immune Response to SARS-CoV-2 in Iceland.冰岛人针对 SARS-CoV-2 的体液免疫反应。
N Engl J Med. 2020 Oct 29;383(18):1724-1734. doi: 10.1056/NEJMoa2026116. Epub 2020 Sep 1.
5
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.轻度新冠肺炎患者体内抗SARS-CoV-2抗体的快速衰减
N Engl J Med. 2020 Sep 10;383(11):1085-1087. doi: 10.1056/NEJMc2025179. Epub 2020 Jul 21.
6
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.